Hälsa & medicin
4.6
🇬🇧 🇮🇹 🇵🇱 🇸🇪 🇺🇸
Probiotic treatment shows promise for protecting premature infants
A new clinical trial tested whether a live bacterial supplement could improve health outcomes in very low birth weight newborns. If effective, the findings could reshape neonatal care protocols and open a new market for microbiome-based therapeutics in one of healthcare's most vulnerable populations.
Originaltitel: Live biotherapeutic product IBP-9414 (L. reuteri) in very low birth weight infants: the Connection Study